General Information


DRACP ID  DRACP04171

Peptide Name  

Sequence  WRAWAKIYHGVGKLLKGVGRW

Sequence Length  21

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C120H181N35O23

Absent amino acids  CDEFMNPQST

Common amino acids  G

Mass  283891

Pl  11.77

Basic residues  6

Acidic residues  0

Hydrophobic residues  10

Net charge  6

Boman Index  -1408

Hydrophobicity  -25.71

Aliphatic Index  92.86

Half Life 
  Mammalian: 20 hour
  Yeast: 30 min
  E.coli: >10 hour

Extinction Coefficient cystines  17990

Absorbance 280nm  899.5

Polar residues  5

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 30506920

Title  Simulated Molecular Evolution for Anticancer Peptide Design

Doi Not available

Year  2019

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  17989

DRACP is developed by Dr.Zheng's team.